SOD1 and amyotrophic lateral sclerosis: Elevated levels of glucosylceramide have been observed in plasma [60], CSF [65] and spinal cords [36] of ALS patients, spinal cords of SOD1-G93A mice [36], motor cortex of SOD1-G93A rats [69], and skeletal muscles of SOD1-G86R mice [67].